Resultados de procura - Maple M. Fung

  • Mostrando 1 - 10 Resultados de 10
Limitar resultados
  1. 1
    Heart disease risk factors predict erectile dysfunction 25 years later

    Heart disease risk factors predict erectile dysfunction 25 years later por Maple M. Fung, Richele Bettencourt, Elizabeth Barrett‐Connor

    Publicado 2004
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Catestatin: A multifunctional peptide from chromogranin A

    Catestatin: A multifunctional peptide from chromogranin A por Sushil K. Mahata, Manjula Mahata, Maple M. Fung, Daniel T. O’Connor

    Publicado 2010
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    Presence of monosodium urate crystal deposition by dual-energy CT in patients with gout treated with allopurinol

    Presence of monosodium urate crystal deposition by dual-energy CT in patients with gout treated with allopurinol por Nicola Dalbeth, Savvas Nicolaou, Scott Baumgartner, Jia Hu, Maple M. Fung, Hyon K. Choi

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Decreased Slow Wave Sleep Increases Risk of Developing Hypertension in Elderly Men

    Decreased Slow Wave Sleep Increases Risk of Developing Hypertension in Elderly Men por Maple M. Fung, Katherine W. Peters, Susan Redline, Michael G. Ziegler, Sonia Ancoli‐Israel, Elizabeth Barrett‐Connor, Katie L. Stone

    Publicado 2011
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Lesinurad Combined With Allopurinol: A Randomized, Double‐Blind, Placebo‐Controlled Study in Gout Patients With an Inadequate Response to Standard‐of‐Care Allopurinol (a US‐Based Study)

    Lesinurad Combined With Allopurinol: A Randomized, Double‐Blind, Placebo‐Controlled Study in Gout Patients With an Inadequate Response to Standard‐of‐Care Allopurinol (a US‐Based S... por Kenneth G. Saag, David Fitzpatrick, Jeff Kopicko, Maple M. Fung, Nihar Bhakta, Scott Adler, Chris Storgard, Scott Baumgartner, Michael A. Becker

    Publicado 2016
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)

    Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinationa... por Thomas Bardin, Robert T. Keenan, Puja Khanna, Jeff Kopicko, Maple M. Fung, Nihar Bhakta, Scott Adler, Chris Storgard, Scott Baumgartner, Alexander So

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Lesinurad monotherapy in gout patients intolerant to a xanthine oxidase inhibitor: a 6 month phase 3 clinical trial and extension study

    Lesinurad monotherapy in gout patients intolerant to a xanthine oxidase inhibitor: a 6 month phase 3 clinical trial and extension study por Anne‐Kathrin Tausche, Rieke Alten, Nicola Dalbeth, Jeff Kopicko, Maple M. Fung, Scott Adler, Nihar Bhakta, Chris Storgard, Scott Baumgartner, Kenneth G. Saag

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial

    Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial por Nicola Dalbeth, Graeme Jones, Robert Terkeltaub, Dinesh Khanna, Jeff Kopicko, Nihar Bhakta, Scott Adler, Maple M. Fung, Chris Storgard, Scott Baumgartner, Fernando Perez‐Ruiz

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Direct Vasoactive Effects of the Chromogranin A (CHGA) Peptide Catestatin in Humans<i>In Vivo</i>

    Direct Vasoactive Effects of the Chromogranin A (CHGA) Peptide Catestatin in Humans<i>In Vivo</i> por Maple M. Fung, Rany M. Salem, Parag Mehtani, Brenda Thomas, Christine F. Lu, Brandon Perez, Fangwen Rao, Mats Stridsberg, Michael G. Ziegler, Sushil K. Mahata, Daniel T. O’Connor

    Publicado 2010
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Heritability and Genome-Wide Linkage in US and Australian Twins Identify Novel Genomic Regions Controlling Chromogranin A

    Heritability and Genome-Wide Linkage in US and Australian Twins Identify Novel Genomic Regions Controlling Chromogranin A por Daniel T. O’Connor, Gu Zhu, Fangwen Rao, Laurent Taupenot, Maple M. Fung, Madhusudan Das, Sushil K. Mahata, Manjula Mahata, Lei Wang, Kuixing Zhang, Tiffany A. Greenwood, Pei-an Betty Shih, Myles Cockburn, Michael G. Ziegler, Mats Stridsberg, Nicholas G. Martin, John B. Whitfield

    Publicado 2008
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: